Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome (a Double-blind Placebo-parallel Group Trial)
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Ivabradine (Primary)
- Indications Postural orthostatic tachycardia syndrome
- Focus Therapeutic Use
- Acronyms POTS
- 06 Nov 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jan 2018.
- 20 Jun 2017 Status changed from not yet recruiting to recruiting.
- 12 Jun 2017 New trial record